Immediate Impact
13 from Science/Nature 76 standout
Citing Papers
Strategies to reduce the risks of mRNA drug and vaccine toxicity
2024 Standout
The evolving role of investigative toxicology in the pharmaceutical industry
2023 Standout
Works of Ard Teisman being referenced
The Concordance between Nonclinical and Phase I Clinical Cardiovascular Assessment from a Cross-Company Data Sharing Initiative
2014
Blockade of the IKs potassium channel: An overlooked cardiovascular liability in drug safety screening?
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ard Teisman | 392 | 381 | 209 | 44 | 676 | |
| Frederick Sannajust | 303 | 304 | 211 | 38 | 781 | |
| Hiroko Izumi‐Nakaseko | 337 | 321 | 142 | 100 | 687 | |
| Leslie Patmore | 323 | 456 | 295 | 32 | 794 | |
| T Nagao | 154 | 390 | 235 | 38 | 714 | |
| L. H. Smith | 169 | 213 | 76 | 28 | 628 | |
| Todd Wisialowski | 397 | 292 | 201 | 37 | 738 | |
| Alan Bass | 351 | 298 | 74 | 35 | 682 | |
| R Méndez | 427 | 225 | 86 | 30 | 648 | |
| Judy Y. Su | 215 | 270 | 135 | 44 | 593 | |
| P Duchêne-Marullaz | 394 | 275 | 110 | 107 | 652 |
All Works
Loading papers...